Cessatech A/S (NGM:CESSA)

Market Cap	484.93M +64.5%
Revenue (ttm)	-6.81M
Net Income	-25.68M
EPS	-1.42
Shares Out	18.58M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,743
Average Volume	53,212
Open	18.90
Previous Close	18.94
Day's Range	18.28 - 18.90
52-Week Range	6.00 - 26.00
Beta	0.76
RSI	43.05
Earnings Date	Feb 27, 2026

About Cessatech

Cessatech A/S, a pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark. The company’s lead product is CT001, an analgesic nasal spray for the treatment of acute and planned painful procedures in children. It also develops CT002, a nasal spray for sedative procedures for children from 0-17 years of age; and CT003, a local anesthetic gel. The company has a collaboration and license agreement with Ventis Pharma Corporation to develop and formulate pain management therapies. Cessatech A/S...

• Industry: Pharmaceutical Preparations
• Founded: 2020
• Employees: 4
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: CESSA

Financial Performance

Financial numbers in DKK